Home » Topics » Regulatory » Patents

Patents
RSS

GlaxoSmithKline presents novel IGF-1R inhibitors for cancer treatment

March 12, 2009

NK3 receptor antagonists claimed by Roche

March 12, 2009

Schering-Plough presents novel alpha2C adrenoreceptor agonists

March 11, 2009

Organon claims TRVP1 modulators for treatment of pain

March 11, 2009

Novel non-nucleoside reverse transcriptase inhibitors claimed by GlaxoSmithKline

March 11, 2009

Novel androgen receptor agonists developed by Takeda

March 11, 2009

GlaxoSmithKline claims quinoxaline derivatives as PI3 kinase inhibitors

March 11, 2009

Novel inhibitors of MDM2 and p53 interaction claimed by Janssen Pharmaceutica

March 11, 2009

Novel bronchodilating isoquinoline amides described by Respiratorius

March 10, 2009

Abbott presents novel 5-HT6 receptor ligands

March 10, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
GSK’s newly acquired Jideytro wins FDA nod in NSCLC
BioWorld
About a week after closing its $10.6 billion acquisition of Nuvalent Inc., GSK plc has reaped the first reward, announcing U.S. FDA approval of zidesamtinib in...